{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T12:37:28Z","timestamp":1781354248480,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF23OC0081536"],"award-info":[{"award-number":["NNF23OC0081536"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.neuint.2024.105717","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T21:33:23Z","timestamp":1709588003000},"page":"105717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Binding of the monoacylglycerol lipase (MAGL) radiotracer [3H]T-401 in the rat brain after status epilepticus"],"prefix":"10.1016","volume":"175","author":[{"given":"Jens D.","family":"Mikkelsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay S.","family":"Aripaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansu B.","family":"Egilmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu A.","family":"Pazarlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2024.105717_bib1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0301-0082(02)00080-1","article-title":"Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids","volume":"68","author":"Alger","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2024.105717_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108897","article-title":"The endocannabinoid system impacts seizures in a mouse model of Dravet syndrome","volume":"205","author":"Anderson","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2024.105717_bib3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/bbrc.1999.0254","article-title":"Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function","volume":"256","author":"Bisogno","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2024.105717_bib4","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chem. Biol."},{"key":"10.1016\/j.neuint.2024.105717_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1567-5769(01)00147-3","article-title":"Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation","volume":"2","author":"Carlisle","year":"2002","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.neuint.2024.105717_bib6","doi-asserted-by":"crossref","first-page":"60S","DOI":"10.2967\/jnumed.121.263201","article-title":"Imaging of synaptic density in neurodegenerative disorders","volume":"63","author":"Carson","year":"2022","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuint.2024.105717_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108394","article-title":"Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases","volume":"244","author":"Chen","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuint.2024.105717_bib8","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1021\/acs.jmedchem.8b00951","article-title":"Identification of ABX-1431, a selective inhibitor of monoacylglycerol lipase and clinical candidate for treatment of neurological disorders","volume":"61","author":"Cisar","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuint.2024.105717_bib9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1124\/jpet.118.252296","article-title":"Monoacylglycerol lipase inhibition in human and rodent systems supports clinical evaluation of endocannabinoid modulators","volume":"367","author":"Clapper","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuint.2024.105717_bib10","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuint.2024.105717_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6667","article-title":"Imaging synaptic density in the living human brain","volume":"8","author":"Finnema","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuint.2024.105717_bib12","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/j.1476-5381.2012.01950.x","article-title":"Monoacylglycerol lipase - a target for drug development?","volume":"166","author":"Fowler","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2024.105717_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrn3482","article-title":"Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction","volume":"14","author":"Goldberg","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2024.105717_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2017.02.033","article-title":"Monoglyceride lipase as a drug target: at the crossroads of arachidonic acid metabolism and endocannabinoid signaling","volume":"175","author":"Grabner","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuint.2024.105717_bib15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1460-9568.2004.03428.x","article-title":"Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala","volume":"20","author":"Gulyas","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2024.105717_bib16","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1021\/acs.jmedchem.8b01576","article-title":"Design, synthesis, and evaluation of (4 R)-1-{3-[2-((18)F)Fluoro-4-methylpyridin-3-yl]phenyl}-4-[4-(1,3-thiazol-2-ylcarbo nyl)piperazin-1-yl]pyrrolidin-2-one ([(18)F]T-401) as a novel positron-emission tomography imaging agent for monoacylglycerol lipase","volume":"62","author":"Hattori","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuint.2024.105717_bib17","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1177\/0271678X211058285","article-title":"Quantification of monoacylglycerol lipase and its occupancy by an exogenous ligand in rhesus monkey brains using [(18)F]T-401 and PET","volume":"42","author":"Hattori","year":"2022","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuint.2024.105717_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.expneurol.2011.11.047","article-title":"Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention","volume":"244","author":"Hofmann","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2024.105717_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/brain\/awab310","article-title":"Enhancing endocannabinoid signalling in astrocytes promotes recovery from traumatic brain injury","volume":"145","author":"Hu","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2024.105717_bib20","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1021\/acs.jmedchem.8b01405","article-title":"Activity-based protein profiling delivers selective drug candidate ABX-1431, a monoacylglycerol lipase inhibitor, to control lipid metabolism in neurological disorders","volume":"61","author":"Jiang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuint.2024.105717_bib21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-neuro-062111-150420","article-title":"Multiple functions of endocannabinoid signaling in the brain","volume":"35","author":"Katona","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2024.105717_bib22","first-page":"294","article-title":"Cannabinoid receptors in the central nervous system: their signaling and roles in disease","volume":"10","author":"Kendall","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuint.2024.105717_bib23","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1124\/jpet.109.155465","article-title":"Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain","volume":"330","author":"Kinsey","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuint.2024.105717_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095922","article-title":"Modulation of pilocarpine-induced seizures by cannabinoid receptor 1","volume":"9","author":"Kow","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2024.105717_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nchembio.129","article-title":"Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects","volume":"5","author":"Long","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuint.2024.105717_bib26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neuroscience.2010.10.062","article-title":"Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus","volume":"174","author":"Ludanyi","year":"2011","journal-title":"Neuroscience"},{"issue":"Suppl. 3","key":"10.1016\/j.neuint.2024.105717_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1528-1167.2010.02624.x","article-title":"Dynamic changes of CB1-receptor expression in hippocampi of epileptic mice and humans","volume":"51","author":"Magloczky","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuint.2024.105717_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuint.2024.105717_bib29","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuroscience.2022.07.020","article-title":"Spatio-temporal alterations in synaptic density during epileptogenesis in the rat brain","volume":"499","author":"Mikkelsen","year":"2022","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2024.105717_bib30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.neuron.2006.07.006","article-title":"The endocannabinoid system controls key epileptogenic circuits in the hippocampus","volume":"51","author":"Monory","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2024.105717_bib31","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1002\/mds.28681","article-title":"Monoacylglycerol lipase inhibition in Tourette syndrome: a 12-week, randomized, controlled study","volume":"36","author":"Muller-Vahl","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2024.105717_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/a-1675-3494","article-title":"Endocannabinoid modulation using monoacylglycerol lipase inhibition in Tourette syndrome: a phase 1 randomized, placebo-controlled study","volume":"55","author":"Muller-Vahl","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neuint.2024.105717_bib33","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.lfs.2012.10.025","article-title":"Therapeutic potential of monoacylglycerol lipase inhibitors","volume":"92","author":"Mulvihill","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2024.105717_bib34","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1209200","article-title":"Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation","volume":"334","author":"Nomura","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.neuint.2024.105717_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13041-022-00931-w","article-title":"Expression profile of synaptic vesicle glycoprotein 2A, B, and C paralogues in temporal neocortex tissue from patients with temporal lobe epilepsy (TLE)","volume":"15","author":"Pazarlar","year":"2022","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuint.2024.105717_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2022.106926","article-title":"Temporal and spatial changes in synaptic vesicle glycoprotein 2A (SV2A) under kainic acid induced epileptogenesis: an autoradiographic study","volume":"183","author":"Pazarlar","year":"2022","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuint.2024.105717_bib37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.celrep.2012.05.001","article-title":"A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease","volume":"1","author":"Piro","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuint.2024.105717_bib38","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022822","article-title":"Epileptogenesis","volume":"5","author":"Pitkanen","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.neuint.2024.105717_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/epi.12461","article-title":"Cyclooxygenase-2 in epilepsy","volume":"55","author":"Rojas","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuint.2024.105717_bib40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.yebeh.2016.11.006","article-title":"Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection","volume":"70","author":"Rosenberg","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuint.2024.105717_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1748-1716.2011.02280.x","article-title":"The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors","volume":"204","author":"Savinainen","year":"2012","journal-title":"Acta Physiol."},{"key":"10.1016\/j.neuint.2024.105717_bib42","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nn.2616","article-title":"Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"Schlosburg","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2024.105717_bib43","article-title":"Expression analysis of CB2-GFP BAC transgenic mice","volume":"10","author":"Schmole","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2024.105717_bib44","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1007\/s00018-018-2834-8","article-title":"Control of excessive neural circuit excitability and prevention of epileptic seizures by endocannabinoid signaling","volume":"75","author":"Sugaya","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuint.2024.105717_bib45","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.celrep.2016.06.083","article-title":"Crucial roles of the endocannabinoid 2-arachidonoylglycerol in the suppression of epileptic seizures","volume":"16","author":"Sugaya","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuint.2024.105717_bib46","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1007\/s00259-021-05671-y","article-title":"First-in-human in vivo imaging and quantification of monoacylglycerol lipase in the brain: a PET study with (18)F-T-401","volume":"49","author":"Takahata","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.neuint.2024.105717_bib47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/epi.13950","article-title":"Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet","volume":"59","author":"Terrone","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuint.2024.105717_bib48","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.nbd.2015.03.016","article-title":"Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice","volume":"77","author":"von Ruden","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2024.105717_bib49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.103.051920","article-title":"The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy","volume":"307","author":"Wallace","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018624000445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018624000445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:04:01Z","timestamp":1759313041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018624000445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":49,"alternative-id":["S0197018624000445"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2024.105717","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Binding of the monoacylglycerol lipase (MAGL) radiotracer [3H]T-401 in the rat brain after status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2024.105717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105717"}}